1. IBM Watson Health.(n.d.). DEFEROXAMINE. IBM Micromedex®. Retrieved August 10, 2021, from https://www-micromedexsolutions-com.medjournal.hmc.psu.edu:2200/micromedex2/librarian/CS/F07FAA/ND_PR/evidencexpert/ND_P/evidencexpert/DUPLICATIONSHIELDSYNC/CCA37D/ND_PG/evidencexpert/ND_B/evidencexpert/ND_AppProduct/evidencexpert/ND_T/evidencexpert/PFActionId/evidencexpert.DoIntegratedSearch?SearchTerm=deferoxamine&UserSearchTerm=deferoxamine&SearchFilter=filterNone&navitem=searchALL#.
2. Label (PDF): Desferal. 2011, August 16th. U.S. Food and Drug Administration. Retrieved August 20th, 2021 from https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016267s050lbl.pdf.
3. Label (PDF): EXJADE. 2005, November 2nd. U.S. Food and Drug Administration. Retrieved August 20th, 2021 from https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021882lbl.pdf.
4. Jadenu (deferasirox) tablets: printed labeling (PDF).2015, March 30th. U.S. Food and Drug Administration. Retrieved August 20th, 2021 from https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206910Orig1s000Lbl.pdf.
5. Label (PDF): FERRIPROX (deferiprone) tablets, for oral use. 2020, February 20th. U.S. Food and Drug Administration. Retrieved August 20th, 2021 from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021825s007lbl.pdf.